BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 32006377)

  • 1. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions.
    Majhi S; Kumar S; Singh L
    CNS Neurol Disord Drug Targets; 2023; 22(5):659-677. PubMed ID: 36915952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Approaches to the Management of Autism Spectrum Disorders.
    Hartman RE; Patel D
    Adv Neurobiol; 2020; 24():547-571. PubMed ID: 32006373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders.
    Bhandari R; Kuhad A
    Life Sci; 2015 Nov; 141():156-69. PubMed ID: 26407474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral inhibition and activation as a modifier process in autism spectrum disorder: Examination of self-reported BIS/BAS and alpha EEG asymmetry.
    Schiltz HK; McVey AJ; Barrington A; Haendel AD; Dolan BK; Willar KS; Pleiss S; Karst JS; Vogt E; Murphy CC; Gonring K; Van Hecke AV
    Autism Res; 2018 Dec; 11(12):1653-1666. PubMed ID: 30475457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of neuroinflammation in Autism Spectrum Disorder.
    Matta SM; Hill-Yardin EL; Crack PJ
    Brain Behav Immun; 2019 Jul; 79():75-90. PubMed ID: 31029798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. School dysfunction in youth with autistic spectrum disorder in Taiwan: The effect of subtype and ADHD.
    Chiang HL; Kao WC; Chou MC; Chou WJ; Chiu YN; Wu YY; Gau SS
    Autism Res; 2018 Jun; 11(6):857-869. PubMed ID: 29427542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.
    Kern JK; Geier DA; King PG; Sykes LK; Mehta JA; Geier MR
    Brain Connect; 2015 Aug; 5(6):321-35. PubMed ID: 25602622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders.
    Bhandari R; Kuhad A
    Neurochem Int; 2017 Feb; 103():8-23. PubMed ID: 28025035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of gut-immune-brain mechanisms in Autism Spectrum Disorder.
    Azhari A; Azizan F; Esposito G
    Dev Psychobiol; 2019 Jul; 61(5):752-771. PubMed ID: 30523646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Gluten in Autism.
    Sumathi T; Manivasagam T; Thenmozhi AJ
    Adv Neurobiol; 2020; 24():469-479. PubMed ID: 32006368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters.
    Santocchi E; Guiducci L; Fulceri F; Billeci L; Buzzigoli E; Apicella F; Calderoni S; Grossi E; Morales MA; Muratori F
    BMC Psychiatry; 2016 Jun; 16():183. PubMed ID: 27260271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Regulation of Reactive Neuroblastosis, Neuroplasticity, and Nutraceuticals for Effective Management of Autism Spectrum Disorder.
    Poornimai Abirami GP; Radhakrishnan RK; Johnson E; Roshan SA; Yesudhas A; Parveen S; Biswas A; Ravichandran VR; Muthuswamy A; Kandasamy M
    Adv Neurobiol; 2020; 24():207-222. PubMed ID: 32006362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everyday executive function impairments predict comorbid psychopathology in autism spectrum and attention deficit hyperactivity disorders.
    Lawson RA; Papadakis AA; Higginson CI; Barnett JE; Wills MC; Strang JF; Wallace GL; Kenworthy L
    Neuropsychology; 2015 May; 29(3):445-53. PubMed ID: 25313979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.
    Qasem H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; El-Ansary A
    Metab Brain Dis; 2018 Aug; 33(4):1141-1153. PubMed ID: 29569150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies.
    Pistollato F; Forbes-Hernández TY; Calderón Iglesias R; Ruiz R; Elexpuru Zabaleta M; Cianciosi D; Giampieri F; Battino M
    Pharmacol Res; 2020 Feb; 152():104579. PubMed ID: 31790820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional interventions for autism spectrum disorder.
    Karhu E; Zukerman R; Eshraghi RS; Mittal J; Deth RC; Castejon AM; Trivedi M; Mittal R; Eshraghi AA
    Nutr Rev; 2020 Jul; 78(7):515-531. PubMed ID: 31876938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder.
    Vuong HE; Hsiao EY
    Biol Psychiatry; 2017 Mar; 81(5):411-423. PubMed ID: 27773355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microbiota in autism spectrum disorders.
    Campion D; Ponzo P; Alessandria C; Saracco GM; Balzola F
    Minerva Gastroenterol Dietol; 2018 Dec; 64(4):333-350. PubMed ID: 29600698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.